Table 2.
Group 1 (non-drug naive) |
Group 2 (drug-naive) |
p | |
---|---|---|---|
N = 978 | N = 221 | ||
Glycemia (mg/dL) | 174 ± 56 | 187 ± 65 | < 0.05 |
Glycated hemoglobin (%) | 8.6 ± 1.6 | 8.9 ± 2.1 | < 0.001 |
Glomerular filtration ratio (mL/min) | 84 ± 24 | 106 ± 34 | < 0.001 |
Albuminuria (mg/g) | 168 ± 170 | 38 ± 101 | < 0.001 |
Total cholesterol (mg/dL) | 198 ± 48 | 212 ± 55 | < 0.001 |
Triglycerides (mg/dL) | 207 ± 115 | 222 ± 154 | 0.8 |
HDL-C(mg/dL) | 43 ± 11 | 41 ± 9 | < 0.05 |
LDL-C (mg/dL) | 115 ± 41 | 130 ± 42 | < 0.001 |
T2DM Type 2 diabetes mellitus, NS Not significant, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol. Group 1 Individuals with T2DM undergoing drug treatment, Group 2 Newly diagnosed drug-naive (< 3 months) patients with T2DM. Statistical significance was set at p < 0.05